Jinseon (Selena) Kim
My research focus is on the insulin-like growth factor (IGF) axis in prostate cancer. Based on associations of high circulating IGF-1 with prostate cancer risk and prostate cancer IGF-1R expression, I’m interested in understanding the consequences of IGF inhibition in prostate cancer upon treatment with an IGF blocking antibody in vitro and in vivo, and through clinical trial in men with newly-diagnosed prostate cancer.
I graduated from Cornell University with a B.A. in Biological Sciences and a minor in Business Administration. Before joining Oxford, I worked as a research assistant in Dr Soberman’s Lab at Harvard Medical School/Massachusetts General Hospital for three years, researching the mechanism and function behind a novel protein highly expressed in recurrent paediatric myeloid leukaemia patients.